ISSN: 3108-5334 | E-ISSN: 2980-2059

Liver Transplantation in Autoimmune Liver Disease [JILTI]
JILTI. 2025; 3(1): 98-104 | DOI: 10.14744/jilti.2025.83803

Liver Transplantation in Autoimmune Liver Disease

Kenan Moral1, Cumali Efe2
1Department of Gastroenterology and Hepatology, Gazi University, Ankara, Türkiye
2Department of Gastroenterology and Hepatology, Harran University, Şanlıurfa, Türkiye

Autoimmune liver diseases, including autoimmune hepatitis, primary biliary cholangitis, and primary sclerosing cholangitis, are the fourth most common cause of transplantation worldwide. Although immunosuppressive therapies can induce remission or slow disease progression, transplantation remains the definitive treatment for patients with end-stage liver disease, intractable symptoms, or acute liver failure. This chapter provides a comprehensive overview of pre- and post-transplant evaluation processes in patients with autoimmune liver diseases.

Keywords: Autoimmune liver disease, chronic rejection, liver transplantation, immunosupression


Corresponding Author: Cumali Efe
Manuscript Language: English
×
APA
NLM
AMA
MLA
Chicago
Copied!
CITE
LookUs & Online Makale